title: Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting.
abstract: This paper describes the development of nonmyeloablative marrow transplant programs that have little toxicity in a canine model and their translation to patients with malignant and nonmalignant hematological diseases.
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA. rstorb@fhcrc.org
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: C
authors.initials: C
authors.lastname: Yu
authors.forename: B M
authors.initials: BM
authors.lastname: Sandmaier
authors.forename: P A
authors.initials: PA
authors.lastname: McSweeney
authors.forename: G
authors.initials: G
authors.lastname: Georges
authors.forename: R A
authors.initials: RA
authors.lastname: Nash
authors.forename: A
authors.initials: A
authors.lastname: Woolfrey
mesh_terms: D000553:Ambulatory Care; D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D016026:Bone Marrow Transplantation / Q000502:physiology*; D004285:Dogs; D006402:Hematologic Diseases / Q000628:therapy; D019337:Hematologic Neoplasms / Q000628:therapy; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D018183:Transplantation Chimera; D014184:Transplantation, Homologous / Q000502:physiology